Quoin Pharmaceuticals Bolsa (NASDAQ: QNRX)

Últimas noticias sobre Quoin Pharmaceuticals (NASDAQ:QNRX) Bolsa

Quoin Pharmaceuticals

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals Ltd

Anthony Scaramucci, CEO of SkyBridge Capital, revealed his significant investments in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), the world's largest cryptocurrency by market capitalization.
What happened: During an interaction with well-known podcaster Natalie Brunell, Scaramucci shared anecdotes about his conversation with MicroStrategy CEO Michael Saylor.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">When <a href="https://twitter.com/Scaramucci?ref_src=twsrc%5Etfw">@Scaramucci</a> wrote a recommendation of 1-3% allocation to <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> in his upcoming book, <a href="https://twitter.com/saylor?ref_src=twsrc%5Etfw">@saylor</a> had something to say about that&#8230; &quot;If you tell somebody to own 2% Bitcoin, that means they have to come up with 50 other ideas as good as Bitcoin! Anthony, do you have 50 other… <a href="https://t.co/DrqasfZN7w">https://t.co/DrqasfZN7w</a> <a href="https://t.co/xuPbeEmUQ2">pic.twitter.com/xuPbeEmUQ2</a>
&mdash; Natalie Brunell &#x26a1;&#xFE0F; (@natbrunell) <a href="https://twitter.com/natbrunell/status/1846527711054868636?ref_src=twsrc%5Etfw">October 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
While <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40825182/anthony-scaramucci-said-last-week-bitcoin-could-touch-up-to-200k-now-hes-thanking-living-l">working on his book</a> "The Little Book of Bitcoin," the foreword of which was penned by Saylor, Scaramucci recalled being asked by fellow Bitcoin bull how much he owned in the apex cryptocurrency.
"55% of my net worth is tied up in Bitcoin," Scaramucci said. "I haven&#8217;t sold any Bitcoin thank God, knock on wood!"
Scaramucci added that initially, he finished his book by presenting a case of allocating around 1-3% of one's portfolio toward Bitcoin. But after Saylor asked him to mention his exposure as well along with the recommendation, he reworded it.
According to Amazon, the book is a guide to understanding the implications of digital asset technology on finance, touching down on basic Bitcoin concepts like blockchain, hashes, and mining.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41349588/cathie-woods-ark-invest-says-ethereum-is-a-big-idea-that-will-transform-the-financial-serv">Cathie Wood&#8217;s Ark Invest Says Ethereum Is A Big Idea That Will Transform The Financial Services Industry — ETH Is Beginning To &#8216;Develop Attributes&#8217; Similar To US Treasury Bills</a>
Why It Matters: A passionate advocate of Bitcoin, Scaramucci predicted last month that the apex cryptocurrency <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40723845/anthony-scaramucci-believes-bitcoin-could-reach-150k-200k-with-king-crypto-wallets-approac">would reach $150,000-$200,000</a> as ownership continues to grow.&nbsp;
Saylor is another prominent Bitcoin bull, holding <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40249632/michael-saylor-says-hes-a-bitcoin-billionaire-heres-how-many-coins-youd-need-to-be-one-you">nearly $1 billion in Bitcoin</a> and intending to buy more in the future.
Price Action: At the time of writing, Bitcoin was exchanging hands at $67,622.70, up 0.47% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. 
Photo by World Economic Forum on Flickr
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41350336/elizabeth-warren-says-rival-john-deaton-wants-to-go-to-washington-to-fight-for-his-crypto-">Elizabeth Warren Says Rival John Deaton Wants To Go To Washington To Fight For His &#8216;Crypto Buddies&#8217; — Republican Fires Back, Claiming He&#8217;s Upset Crypto Billionaires More Than Anyone Else</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$BTC

Anthony Scaramucci Tells What Percentage Of His Wealth Is Tied Up In Bitcoin: 'I Haven't Sold Any. Thank God, Knock On Wood!'

As <a href="https://www.benzinga.com/topic/psilocybin">psilocybin</a> slowly gains acceptance as a <a href="https://www.benzinga.com/topic/psilocybin-assisted-therapy">potential mental health treatment</a>, websites claiming to sell magic mushrooms are multiplying online, operating in a gray area of legality. As DoubleBlind <a href="https://doubleblindmag.com/selling-mushrooms-on-the-internet/">reported</a>, while psilocybin remains a <a href="https://www.benzinga.com/topic/federal-schedule-i">Schedule I</a> substance in the U.S., these sites are capitalizing on the possibility of future legalization, following a path similar to that of cannabis.
<h3 class="wp-block-heading">Safety Concerns Mount As Unregulated Psychedelics Hit The Web</h3>
A simple Google search reveals websites like Shroomsnearme.com, which connects users to local mushroom suppliers, and Fungimaps.com, which models itself after <a href="https://www.benzinga.com/topic/weedmaps">WeedMaps</a>, offering directories of mushroom delivery services. Some sites, however, sell products directly to consumers, utilizing vague packaging and terminology to hint at their psychedelic content without explicitly stating it. A product like Ms. Mollie Cule tablets, for instance, claims to contain "pure mushroom essence," leaving buyers to interpret what that actually means.
The unregulated market is raising red flags among experts. Dr. Brian Pilecki, a licensed psilocybin facilitator in Oregon, notes the psychological risks involved when buyers don't fully trust their source. "Having any doubt [about] the environment or the situation can be seeds for paranoia, fear, or a number of adverse reactions during a psilocybin experience," he warns.
But as the industry continues to evolve, safety concerns remain. A recent <a href="https://doubleblindmag.com/notes-from-the-underground-mushroom-market/">investigation</a> by DoubleBlind revealed that many psychedelic products, available both online and in stores, contain synthetic substances like <a href="https://www.benzinga.com/markets/cannabis/24/08/40492487/deaths-and-severe-illness-linked-to-diamond-shruumz-products-experts-blame-reckless-manufacturin">4-AcO-DMT</a>. While some synthetic psychedelics are considered non-toxic, others may pose significant health risks due to the lack of regulation and quality control.
<h3 class="wp-block-heading">Legal Loopholes And Lack of Enforcement Drive Growth</h3>
Despite the risks, the market continues to grow, with many online vendors <a href="https://www.benzinga.com/markets/cannabis/22/11/29872683/metas-instagram-is-the-to-go-platform-for-illegal-weed-dealers-heres-why">mimicking the rise of cannabis services before widespread legalization</a>. Jodi Green, an attorney specializing in the regulatory landscape of cannabis and psychedelics, notes that these vendors are banking on the lack of federal enforcement. "People are simply agreeing to take the risk, assuming the federal government doesn't have the resources to chase after them."
As the psychedelic market grows, the legal landscape remains murky, leaving consumers to navigate a market with little assurance of product safety or legality. Until regulations are in place, experts continue to advise that the best rule for those experimenting with psychedelics remains: know and trust your source.
Cover image made with AI

Cannabis

Psychedelics

Regulations

Retail Sales

Online Mushroom Market Booms: Experts Say Be Very Careful

Peter Schiff, a renowned economist and financial commentator, has expressed his views on former President Donald Trump&#8217;s tariff strategy, advocating instead for lower taxes and fewer regulations.
What Happened: On Wednesday, Schiff took to X to criticize Trump&#8217;s approach to tariffs, stating, &#8220;Trump can&#8217;t impose tariffs on China. He can only impose tariffs on Americans who buy Chinese products.&#8221; 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Trump can&#39;t impose tariffs on China. He can only impose tariffs on Americans who buy Chinese products.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1846650698080887136?ref_src=twsrc%5Etfw">October 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He further responded to a user advocating for the return of production to the U.S., stating, &#8220;We need to. But tariffs won&#8217;t make that happen. We need lower taxes and fewer regulations, particularly related to employment.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We need to. But tariffs won&#39;t make that happen. We need lower taxes and fewer regulations, particularly related to employment.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1846651214097695177?ref_src=twsrc%5Etfw">October 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
This comes amidst a broader discussion on the impact of tariffs on the U.S. economy, with various influential figures expressing their views on the matter.
Schiff said the point that was lost in all &#8220;China bashing&#8221; was that the country was one of the &#8220;main reasons the [Fed] has been able to create so much [inflation] under the guise of QE without pushing consumer prices and long-term interest rates much higher.&#8221;
He said in a separate post on X, &#8220;We exported our inflation and imported their consumer goods.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Lost in all the <a href="https://twitter.com/hashtag/China?src=hash&amp;ref_src=twsrc%5Etfw">#China</a> bashing is that China is one of the main reasons the <a href="https://twitter.com/hashtag/Fed?src=hash&amp;ref_src=twsrc%5Etfw">#Fed</a> has been able to create so much <a href="https://twitter.com/hashtag/inflation?src=hash&amp;ref_src=twsrc%5Etfw">#inflation</a> under the guise of QE without pushing consumer prices and long-term interest rates much higher. We exported our inflation and imported their consumer goods.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1846637282184589620?ref_src=twsrc%5Etfw">October 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41319060/s-p-500-extends-record-highs-dow-breaks-43-000-ahead-of-pivotal-earnings-week-bitco?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">S&amp;P 500 Extends Record Highs, Dow Breaks 43,000 Ahead Of Pivotal Earnings Week, Bitcoin&#8217;s Rally Lifts Crypto Stocks: What&#8217;s Driving Markets Monday?</a>
Why It Matters: Schiff&#8217;s comments add to the ongoing debate on the effectiveness of tariffs as a tool for economic policy. His views contrast with those of Trump, who has been vocal about the use of tariffs to revitalize U.S. manufacturing. <a href="https://www.benzinga.com/news/24/10/41348822/mark-cuban-says-he-knows-what-trump-wants-to-achieve-with-tariffs-but-the-ex-president-has-no-idea-w">Mark Cuban</a>, billionaire and &#8220;Shark Tank&#8221; star, recently expressed skepticism about Trump&#8217;s approach, suggesting that a law requiring all manufacturing to be done in the U.S. within a decade would be more effective.
Trump defended his <a href="https://www.benzinga.com/general/politics/24/10/41344136/trump-goes-on-the-defense-about-massive-effect-of-tariffs-economic-growth-putin-relationship-djt">tariff strategy</a> in a recent interview at the Economic Club of Chicago, asserting that tariffs have a &#8220;massive effect&#8221; on economic growth.
The debate on tariffs versus taxes <a href="https://www.benzinga.com/real-estate/24/10/41333498/trumps-tariffs-vs-harriss-taxes-which-will-hit-luxury-real-estate-harder-experts-weigh-in">continues to be a key issue</a> ahead of the 2024 presidential election, with potential impacts on various sectors, including luxury real estate.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Politics

Media

General

Trump Can't Impose Tariffs On China, Says Peter Schiff: 'He Can Only Impose Tariffs On Americans Who Buy Chinese Products'

In a recent interview with Fox News, Vice President Kamala Harris sidestepped questions regarding the Biden administration&#8217;s immigration policies. The interview, conducted by Bret Baier, saw Harris deflecting inquiries about the number of illegal immigrants released into the country and the reversal of Trump-era policies.
What Happened: During the interview, Baier questioned Harris about the Biden administration&#8217;s immigration record. Harris, however, shifted the focus towards the need for immigration system reform. 
She was asked about the number of immigrants illegally in the country to which she responded by saying, &#8220;Bret, let&#8217;s just get to the point, ok?&#8221; 
&#8220;The point is that we have a broken immigration system that needs to be repaired.&#8221;
When asked about the reversal of Trump-era policies like Remain in Mexico, Harris pointed out the Biden administration&#8217;s initial legislative push for immigration reform and accused Trump of blocking a bipartisan immigration bill.
Baier also brought up the tragic cases of Jocelyn Nungaray, Rachel Morin, and Laken Riley, all victims of violent illegal immigrants who entered the country during the Biden administration. Harris expressed her sympathy for the victims&#8217; families and emphasized the need for more border agents and support for those working to prevent future harm.
See Also: <a href="https://www.benzinga.com/government/24/10/41308384/mark-cuban-clashes-with-bill-ackman-after-billionaire-fund-manager-calls-kamala-harris-startup-tax-d?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mark Cuban Clashes With Bill Ackman After Billionaire Fund Manager Calls Kamala Harris&#8217; Startup Tax Deduction Proposal &#8216;Extremely Misleading:&#8217; &#8216;We Need To Get You Watching Shark Tank&#8217;</a>
Harris was asked when did the border start becoming a crisis. In response she said, &#8220;We&#8217;ve had a broken immigration system transcending, by the way, Donald Trump&#8217;s administration, even before. Let&#8217;s all be honest about that.&#8221;
&#8220;I have no pride in saying that this is a perfect immigration system. I&#8217;ve been clear. I think we all know that it needs to be fixed. &#8220;
Why It Matters: The interview had sparked <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41366181/kamala-harriss-fox-news-interview-will-likely-mention-project-2025-israel-and-one-other-co">considerable speculation</a> among prediction market traders about the topics Harris would address. The top subjects expected to be mentioned included Abortion, Project 2025, Israel, and Medical Records.
Harris <a href="https://www.benzinga.com/news/24/10/41348386/trump-falls-3-points-behind-harris-in-new-poll-economic-worries-dominate-voter-concerns-report">held a slim lead</a> over Republican Donald Trump in the latest Reuters/Ipsos poll. The poll suggested a potential rise in voter enthusiasm, especially among Democrats, compared to the 2020 presidential election.
Both Harris and Trump were <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41370777/trump-harris-consider-joe-rogan-podcast-could-spotify-ride-2024-election-wave-analy">considering appearances</a> on &#8220;The Joe Rogan Experience&#8221; podcast ahead of the 2024 presidential election, potentially impacting media stocks and advertising spend.
Photo courtesy: Wikimedia
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Kamala Harris Pulls A Reverse Card, Puts Trump At Fault For Border Crisis In Fox News Interview: 'Let's Just Get To The Point, Ok?'

Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) is trading higher by 10% to the $0.000018-level over the trailing week. Strength comes amid a broader market rally driven by Bitcoin, trading near the <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41367220/bitcoin-ethereum-dogecoin-trade-like-no-bear-market-on-the-horizon-trader-predicts-all-tim">$67,000-level</a>.&nbsp;
The surge in Bitcoin has taken 96% of its holders into profit, boosting sentiment across the crypto sector, including Shiba Inu.
Shiba Inu's history of surging alongside its meme coin counterpart Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), which is up 15% over the past week, adds weight to the argument that a speculative rally could follow in the near future.
What Else: As Bitcoin and Ethereum draw more institutional and retail interest, some of that attention is naturally spilling over to smaller altcoins like Shiba Inu, which can experience rapid price swings in response to overall market excitement.
Additionally, the <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41313376/bitcoin-closes-in-on-65k-as-etfs-see-over-400m-in-net-inflows">recent surge in blockchain equity ETFs</a>, which recently saw their largest weekly inflows of the year, is contributing to a broader wave of positive sentiment across the crypto sector. This institutional inflow not only boosts confidence in established cryptocurrencies but also strengthens market momentum for speculative assets like Shiba Inu.
Read Also: <a href="https://www.benzinga.com/fintech/24/10/41371235/robinhood-announces-futures-trading-index-options-trading">Robinhood Announces Futures Trading, Index Options Trading</a>
Why This Matters: Originally launched as a <a href="https://www.benzinga.com/topic/meme-coins">meme coin</a>, Shiba Inu has evolved beyond its playful origins to become a serious contender in the cryptocurrency world, bolstered by a passionate community and its expanding ecosystem, which includes decentralized exchanges and <a href="https://www.benzinga.com/topic/nfts">NFT</a> initiatives. 
Shiba Inu's low cost per token and potential for explosive price movements make it particularly appealing to retail investors looking to diversify their crypto holdings during bullish market phases.
Shiba Inu's rising popularity is also linked to its accessibility for smaller investors. Its extremely low price per token allows for speculative plays with less capital, offering exposure to potential gains driven by social media buzz and community-driven projects.&nbsp;
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41357154/crypto-lobbyists-are-quietly-influencing-2024-election-this-is-their-playbook">Crypto Lobbyists Are Quietly Influencing 2024 Election: This Is Their Playbook</a>
What&#8217;s Next: The influence of altcoins is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19.

$DOGE

$SHIB

Why Dogecoin Rival Shiba Inu Is Up 10% Over The Past Week

In Paraguay, the industrial cannabis sector is celebrating. They&#8217;ve <a href="https://www.ip.gov.py/ip/2024/10/15/paraguayan-cannabis-conquers-europe-european-market-buys-entire-flower-production/">announced</a> reaching a milestone as the European market has purchased the entirety of the country's premium cannabis flower production for 2024. 
The agreement marks a key moment in Paraguay's expanding role in the global cannabis market, particularly in <a href="https://www.benzinga.com/markets/cannabis/24/06/39442869/2-9b-european-cannabis-market-a-strategic-blueprint-for-cross-border-transportation-logistics">Eastern Europe</a>, where demand for high-quality cannabis products is growing.
<h3 class="wp-block-heading">Crafting Of Success</h3>
The deal was <a href="https://www.ip.gov.py/ip/2024/10/15/paraguayan-cannabis-conquers-europe-european-market-buys-entire-flower-production/">confirmed</a> by the government following a series of developments earlier this year when a shipment of cannabis flower samples was sent from Paraguay to Europe. The high quality of the flowers captured the attention of European entrepreneurs, prompting them to visit Paraguay.
During their visit, they sealed the agreement and introduced advanced technology to enhance the preservation and <a href="https://www.benzinga.com/markets/cannabis/24/07/39739336/govt-owned-cannabis-company-exports-flower-from-argentina-to-eu-australia-secures-purchase-order">transportation of the flowers</a>.
"They brought a technology called freeze-drying. Producers harvest the cannabis flowers and place them in refrigerated containers at -30 degrees. The flowers are frozen fresh, not dried. This way, the production is bought fresh and green," explained Marcelo Demp, president of the Paraguayan Chamber of Industrial Cannabis (CCIP) to <a href="https://infonegocios.com.py/infoagro/mercado-europeo-asegura-el-100-de-la-produccion-anual-de-flores-de-cannabis-paraguayo">Infonegocios</a>. This innovative method ensures that the flowers maintain their quality during transportation to Europe, a crucial factor for markets with high standards.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39442869/2-9b-european-cannabis-market-a-strategic-blueprint-for-cross-border-transportation-logistics">$2.9B European Cannabis Market: A Strategic Blueprint For Cross-Border Transportation Logistics</a>
<h3 class="wp-block-heading">Expanding Production To Meet Demand</h3>
The Paraguayan plantations involved in this agreement are located in Areguá, Nueva Italia, Iruña and Hernandarias. Although precise production volumes cannot yet be confirmed due to variable crop yields, Demp estimates a minimum yield of 5 tons per hectare, potentially generating up to $25,000 per hectare.
Despite this success, Demp acknowledged that current production levels are not yet sufficient to fully meet European demand. 
As a result, the CCIP is actively seeking more producers to join the industry to boost the sector's capacity and ensure Paraguay's position in the growing global cannabis market.
In September, neighbor Argentina also made a significant move in the global cannabis market by <a href="https://www.benzinga.com/markets/cannabis/24/06/39173275/argentina-targets-europe-with-major-cannabis-export-deals">exporting medicinal cannabis </a>to Switzerland and partnering with Germany&#8217;s Cantourage Group SE to introduce Patagonia Heritage's products to Europe.
Prior to that, another Argentine state-owned company completed its <a href="https://www.benzinga.com/markets/cannabis/24/07/39739336/govt-owned-cannabis-company-exports-flower-from-argentina-to-eu-australia-secures-purchase-order">first export of cannabis flowers</a> to Europe and Australia, securing contracts worth $5.4 million annually for therapeutic use.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Rapid Growth Since 2019</h3>
The industrial cannabis industry in Paraguay, which only began in 2019 after the approval of its legal framework, has experienced exponential growth. 
In just five years, the country has exported <a href="https://www.benzinga.com/markets/cannabis/21/08/22359616/paraguay-to-export-cannabis-oil-to-usa-and-australia">over 600 tons of cannabis products</a> and raw materials to various international markets. Products such as gummies, infusions and cannabis derivatives have also helped Paraguay boost its primary production.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/06/39173275/argentina-targets-europe-with-major-cannabis-export-deals">Argentina Targets Europe With Major Cannabis Export Deals</a></li>
</ul>
Cover: AI generated image

Latin America

Guaraní Cannabis Lands In Europe: Paraguay To Export 100% Of Its Flower Production

A Georgia judge has overturned several controversial election rules, asserting that the Pro-Trump GOP-majority Georgia Election Board does not have the authority to enforce them.
What Happened: Fulton County Superior Court Judge Thomas Cox Jr. ordered the rejection of seven rules, including the requirement for hand-counted ballots by precinct, ahead of the November elections, as reported by <a href="https://thehill.com/homenews/state-watch/4937832-judge-rejects-controversial-rules-including-hand-count-rule-from-georgia-board/">The Hill</a>.
Judge Cox stated in his ruling that the Georgia Election Board &#8220;has no constitutional authority to promulgate these rules.&#8221; He added that the U.S. Constitution prohibits the State Board Election from enacting election rules concerning the election of federal officers.
The Georgia Election Board has been under fire for passing controversial rules months before the election. Even some of the state&#8217;s top Republicans have expressed concern over some of the rulemaking, particularly the hand-count law.
The rules and Cox&#8217;s recent decision are particularly significant as Georgia is among a few battleground states that will decide if former President Donald Trump or Vice President Kamala Harris return to the White House. Trump won Georgia in 2016 but lost it to President Biden in 2020.
See Also: <a href="https://www.benzinga.com/news/24/10/41348822/mark-cuban-says-he-knows-what-trump-wants-to-achieve-with-tariffs-but-the-ex-president-has-no-idea-w?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mark Cuban Says He Knows What Trump Wants To Achieve With Tariffs But The Ex-President Has No Idea What It Takes To Do It — &#8216;That&#8217;s How Crazy His Approach Is&#8217;</a>
Why It Matters: The decision comes at a critical time as the race for the White House has become <a href="https://www.benzinga.com/news/24/10/41331062/trump-vs-harris-vice-president-goes-from-deficit-to-slender-lead-in-new-poll-but-battleground-states">too close for comfort</a>. Vice President Harris led her Republican rival Trump by merely a point in a recent poll. The same report also highlighted that battleground states favor the ex-president, making the Georgia ruling even more significant.
Harris&#8217; <a href="https://www.benzinga.com/general/politics/24/10/41347642/harris-vs-trump-vice-president-holds-lead-in-2024-election-poll-but-former-president-is-closing-">lead over Trump has been shrinking</a>, with less than one month until the 2024 presidential election. The Georgia ruling could potentially impact the election outcome, given the state&#8217;s pivotal role in the electoral landscape.
Image via Shutterstock
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Trump-Harris Race: Georgia Judge Overrules Republican-Enforced Election Rules Ahead Of Crucial November Elections: 'No Constitutional Authority To Promulgate'

PEGY

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Vice President Kamala Harris is gaining praise from cannabis industry leaders for her plans to federally legalize marijuana, which advocates believe could unlock significant economic <a href="https://www.benzinga.com/markets/cannabis/24/06/39319868/meet-the-man-who-did-prison-time-for-non-violent-cannabis-offense-and-now-advocates-for-others-i">opportunities for Black men. </a>
In a recent op-ed, The Cannabis Vanguard a coalition of cannabis professionals, applauded Harris' proposal as a step toward addressing the lasting harm caused by marijuana criminalization, particularly in Black communities.
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41314909/kamala-harris-unveils-policy-plan-for-black-men-focusing-on-economic-opportunity-health-cannabis">Kamala Harris Unveils Policy Plan For Black Men, Focusing On Economic Opportunity, Health, Cannabis Legalization</a>
In their op-ed, titled "The Next President Is Ready to Legalize Cannabis for Black Men," the group outlines how Harris&#8217; plan would help dismantle the systemic obstacles that have disproportionately affected Black men, who have faced over-policing for marijuana-related offenses for decades.
<h3 class="wp-block-heading">Opening Economic Doors Through Legalization</h3>
Harris' proposal to legalize marijuana at the federal level is at the heart of her "Opportunity Agenda" proposal for Black men, presented on Monday. By working with Congress to "make the safe cultivation, distribution, and possession of recreational marijuana the law of the land," Harris aims to create a more inclusive market.
The Cannabis Vanguard (TCV) argues that a key component of this effort should be federal grants and loan programs targeting Black entrepreneurs and individuals impacted by marijuana criminalization.
Modeled after state-level programs like Illinois&#8217; Cannabis Social Equity Program, these initiatives would provide capital and support to aspiring cannabis business owners who might otherwise be shut out due to financial or legal barriers.
<h3 class="wp-block-heading">Expungement And A Path To Justice</h3>
One of the most transformative parts of Harris' cannabis platform, according to TCV, is the push for automatic expungement of nonviolent marijuana convictions. 
"Expungement removes barriers to employment, housing, education, and financial aid, allowing individuals to rebuild their financial lives," the op-ed says. 
<h3 class="wp-block-heading">Addressing Housing Barriers</h3>
Another critical area that The Cannabis Vanguard wants to see reformed is federal housing policies that exclude people with marijuana-related convictions from receiving housing assistance, such as Section 8. 
TCV says that creating cannabis-specific housing assistance programs would stabilize the housing situation for many Black men affected by past convictions. These reforms could open the door to homeownership and long-term wealth-building opportunities for those previously denied access to federal assistance.
<h3 class="wp-block-heading">Job Creation Through Cannabis</h3>
The op-ed also stresses the importance of tax incentives for cannabis companies that hire individuals with nonviolent marijuana convictions.
TCV believes that encouraging the industry to provide job opportunities for those with prior records would not only reduce unemployment but also give formerly incarcerated individuals a chance to thrive in a legal market.
<h3 class="wp-block-heading">A Vision For Justice And Economic Equality</h3>
The organization sees Harris' cannabis policy as an opportunity to right the wrongs of decades of marijuana criminalization. They argue that federal legalization, paired with strategic initiatives like expungement and targeted grants, could play a pivotal role in closing the racial wealth gap and helping Black men achieve economic stability.
"With legalization, our future president and Congress could address the longstanding economic harm done to Black men and other marginalized communities," The Cannabis Vanguard concludes.
The group's founding members include Wanda L. James, CEO of Simply Pure; Gia Morón, CEO of GVM Communications; Toi Hutchinson, former Illinois Cannabis Czar and State Senator; Roz McCarthy, CEO of Minorities for Medical Marijuana; Shanita Penny, Principal of Budding Solutions and Linda Mercado Greene, CEO of Anacostia Organics.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41362831/kamala-harris-agrees-trump-is-a-fascist-in-interview-with-charlamagne-tha-god-yes-we-can-say-tha">Kamala Harris Agrees Trump Is A Fascist In Interview With Charlamagne Tha God: &#8216;Yes, We Can Say That&#8217;</a></li>
</ul>
Image courtesy: The Cannabis Vanguard.

Kamala Harris' Marijuana Plan Could 'Remove Barriers To Employment, Housing And Education For Black Men' Industry Leaders Say

Robinhood Markets, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) CEO Vlad Tenev delivered the keynote speech about exclusive product announcements to kick off the company's HOOD Summit 2024<a href="https://www.benzinga.com/partner/news/24/10/41366442/active-traders-and-investors-could-find-significant-balance-boosts-during-robinhoods-upcoming-hood-w"> in Miami, Florida. </a>
The Details: Tenev announced the launch of futures trading and index options trading in a major expansion of the platform's offerings. The Robinhood CEO said index options will be available for trading in the coming months with extended-hours trading available next year. 
Tenev did not give a timeframe for the rollout of futures trading in his speech. 
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41340022/amazon-analyst-expects-q3-earnings-with-revenue-growth-margin-expansion-relative-st">Amazon Analyst Expects Q3 Earnings With Revenue Growth, Margin Expansion, Relative Stable E-Commerce Demand</a>
Tenev also recapped Robinhood's <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41236863/robinhood-eyes-major-growth-with-new-trading-features-while-coinbase-rides-crypto-s">platform improvements</a> over the past year including the addition of joint investment accounts, simulated options returns and reduced margin rates to the lowest among leading trading platforms. The CEO highlighted Robinhood's achievement of becoming the first retail brokerage to offer 24-hour trading of single-name stocks in the U.S. with more than 1,000 symbols available for 24-hour trading.&nbsp;
Robinhood's HOOD Summit 2024 <a href="https://go.robinhood.com/events">features speakers</a>, panel discussions and demonstrations on trading technology, investing and culture and continues through Oct. 18 in Miami, Florida.&nbsp;
HOOD Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Robinhood shares ended Wednesday's session 0.49% higher at $26.93. After-hours trading sees stock up 3.04% at $27.75.&nbsp;&nbsp;
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41370426/pepsi-fights-back-against-shrinkflation-why-your-chip-bags-will-be-fuller-in-the-future">Pepsi Fights Back Against Shrinkflation: Why Your Chip Bags Will Be Fuller In The Future</a></li>
</ul>
Photo: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

Futures

Options

After-Hours Center

Movers

HOOD

Robinhood Announces Futures Trading, Index Options Trading

Trading Halt: Halted at 7:12:26 p.m. ET - Trading Halt: Halt News Pending

Great Southern Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSBC#NASDAQ">GSBC</a>) reported quarterly earnings of $1.41 per share which beat the analyst consensus estimate of $1.26 by 11.9 percent. This is a 6.02 percent increase over earnings of $1.33 per share from the same period last year. The company reported quarterly sales of $47.98 million which missed the analyst consensus estimate of $51.01 million by 5.95 percent. This is a 2.65 percent increase over sales of $46.74 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

GSBC

Great Southern Bancorp Q3 EPS $1.41 Beats $1.26 Estimate, Sales $47.98M Miss $51.01M Estimate

Media stocks are set to benefit from advertising spend by politicians, presidential debates and media appearances by presidential candidates during the <a href="https://www.benzinga.com/topic/2024-election">2024 election cycle.</a>
Music streaming platform Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) could turn out to be one of the underrated winners of the election season if it can grab interviews with both presidential candidates on one of the company's popular podcasts.
What Happened: Both Vice President Kamala Harris and Donald Trump are rumored to be making appearances on "The Joe Rogan Experience" podcast ahead of the <a href="https://www.benzinga.com/general/entertainment/24/10/41324364/kamala-harris-eyes-appearance-on-joe-rogan-experience-to-appeal-to-male-voters-as-president">2024 presidential election.</a>
Trump, who has never appeared on the podcast, <a href="https://x.com/nelkboys/status/1845292385850540122">confirmed </a>his appearance during an appearance on the "Full Send" podcast.
Harris is rumored to be considering going on the podcast as she continues<a href="https://www.benzinga.com/general/entertainment/24/10/41214476/will-kamala-harriss-media-blitz-including-60-minutes-and-call-her-daddy-improve-her-2024-el"> her media blitz </a>that has included appearances on television and podcasts in recent weeks, targeting multiple different voter demographics.
"The Joe Rogan Experience" podcast, hosted by Joe Rogan, is among the top listened-to podcasts in the U.S. and a major subscriber driver for Spotify. The music company said earlier this year Rogan <a href="https://www.benzinga.com/news/24/03/37886499/joe-rogan-dominates-spotify-podcast-scene-with-triple-the-followers-of-nearest-competitor">had 14.5 million followers</a> on the platform. Rogan has been number one on Spotify for <a href="https://www.benzinga.com/general/entertainment/23/11/36004998/joe-rogan-tops-spotifys-2023-podcasts-list-once-again-deal-likely-to-expire-in-2024-a-major">four straight years.</a>
Rogan has been exclusive to Spotify since 2020 and earlier this year <a href="https://www.benzinga.com/markets/equities/24/02/36914209/spotify-inks-multiyear-deal-with-podcast-king-joe-rogan-amid-shifting-strategy">signed a multiyear renewal</a> worth a reported $250 million.
While Rogan will likely get huge viewership figures ahead of the 2024 election as he talks about political topics and has noteworthy guests, drawing one or both of Trump and Harris, who have never appeared on the podcast, could be among the most highly anticipated shows in his history.
Spotify could stand to benefit as the company might see a boost in subscribers, target advertising dollars and offer bundles ahead of the podcast appearances to take advantage of the interviews.
While Trump has often commanded strong viewership figures for his media appearances, Harris recently helped "The View" post its best ratings in three and a half years. Harris' appearance on the Oct. 8 episode averaged 3.14 million, marking the most watched episode of the daytime show since Feb. 2021, as reported by <a href="https://variety.com/2024/tv/news/kamala-harris-the-view-ratings-best-1236179122/">Variety</a>.
The strong viewership helped "The View" win the week for total viewers among its peers.
While Trump confirmed his appearance, consumers aren't convinced Harris will make an appearance with the sometimes controversial Rogan. A prediction market on Polymarket <a href="https://polymarket.com/event/will-kamala-go-on-joe-rogan-before-election">lists </a>a 33% chance of Harris going on the podcast.
On Polymarket, users can deposit funds using&nbsp;USDC&nbsp;(CRYPTO:&nbsp;<a href="https://www.benzinga.com/quote/">USDC</a>) via the&nbsp;Polygon&nbsp;(CRYPTO:&nbsp;<a href="https://www.benzinga.com/quote/matic/usd">MATIC</a>) network, or directly from a crypto account with&nbsp;Ethereum&nbsp;(CRYPTO:&nbsp;<a href="https://www.benzinga.com/quote/eth/usd">ETH</a>). In each betting market, the winning option pays out at $1.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent101624">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Spotify Growth Potential: An appearance by Harris and/or Trump on "The Joe Rogan Experience" could help boost the growth prospects for Spotify, but an analyst sees future growth coming without either interview.
KeyBanc Capital Markets analyst Justin Patterson reiterated an Overweight rating and raised the price target on Spotify from $440 to $490.
The analyst said Spotify is "finding the sweet spot of growth and margin."
Spotify reports third-quarter financial results on Nov. 12, which is coincidentally a week after the 2024 election.
With improved growth and profitability, the analyst raises estimates for several financial metrics ahead of the earnings print.
Patterson sees Spotify reporting net adds of 13 million monthly active users and 5 million premium subscribers.
"Given less disruption from bundles, we believe Spotify could outperform both metrics."
The analyst said there could be some upside in guidance based on bundle rollouts. Patterson is also bullish on a potential coming catalyst that could be announced by the company soon.
"There are growing signs that a high-end plan will be launched in the coming months."
Patterson said revenue growth, steady margin expansion and capital returns are all items that could help send Spotify shares higher.
"We continue to believe there is meaningful upside to Street profitability forecasts. We continue to view valuation as compelling.
SPOT Price Action: Spotify shares closed down 0.24% to $371.69 on Wednesday versus a 52-week trading range of $145.76 to $389.23. Spotify stock is up 96% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/sports-betting/24/10/41347270/trump-vs-harris-2024-election-polls-sportsbooks-betting-odds-show-different-winners-for-20">Trump Vs. Harris: 2024 Election Polls, Sportsbooks Betting Odds Show Different Winners For 2024 Election</a></li>
</ul>
Photo: Courtesy Joe Rogan Experience

Analyst Color

Entertainment

Price Target

Reiteration

Analyst Ratings

Trading Ideas

$ETH

$MATIC

$USDC

SPOT

Trump, Harris Consider Joe Rogan Podcast: Could Spotify Ride 2024 Election Wave? Analyst Says Company In 'Sweet Spot Of Growth'

Calumet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMT#NASDAQ">CLMT</a>) and Gevo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) shares are on the move in extended trading Wednesday after the companies received conditional commitments from the <a href="https://www.benzinga.com/pressreleases/24/10/g41369229/gevo-secures-conditional-commitment-from-u-s-department-of-energy-loan-programs-office-for-its-net">U.S. Department of Energy (DOE)</a>.
What Happened With CLMT: Calumet announced Wednesday that the DOE Loan Programs Office awarded a conditional commitment for a loan guarantee of up to&nbsp;$1.44 billion&nbsp;to fund the construction and expansion of a renewable fuels facility owned by Calumet subsidiary Montana Renewables.
The loan guarantee is structured in two tranches.&nbsp;The first tranche of approximately $778 million is expected to close in the fourth quarter and be disbursed from 2025 through the anticipated completion of the project in 2028. A&nbsp;$150 million&nbsp;equity investment will also be made at the initial closing.
&#8220;Through our collaboration with the U.S. Department of Energy, we are thrilled to continue forward on the leading edge of our nation&#8217;s Sustainable Aviation Fuel transition,&#8221; said&nbsp;Todd Borgmann, CEO of Calumet. 
&#8220;This investment will allow us to leverage our first-mover advantage and unique renewable hydrogen and pretreatment technologies to transform Montana Renewables into a world scale SAF producer.&#8221;
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41366736/netflix-q3-earnings-preview-ad-supported-plan-price-hikes-and-content-slate-key-foc">Netflix Q3 Earnings Preview: Ad-Supported Plan, Price Hikes, And Content Slate Key Focus As Company &#8216;Adds More And More Live Content&#8217;</a>
What Happened With GEVO: Gevo was also awarded a conditional commitment for a loan guarantee from the DOE&#8217;s Loan Programs Office, with disbursements totaling&nbsp;$1.46 billion. The commitment is related to the construction of the company&#8217;s Net-Zero 1 project (NZ1) in South Dakota.&nbsp;
&#8220;This marks a watershed moment for the Net-Zero 1 project and a critical step forward in Gevo&#8217;s mission to transform the aviation industry by providing a scalable, sustainable, and economical renewable-carbon-based jet fuel — SAF,&#8221; said Patrick Gruber, CEO of Gevo.
&#8220;This valuable commitment to help finance NZ1, if finalized, should also attract other capital investments to unlock SAF commercialization given the robust due diligence conducted by the agency.&#8221;
CLMT, GEVO Price Action: At publication time after market hours, Calumet shares were up 19.74% at $26.26 and Gevo shares were up 46.22% at $3.28, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Government

Financing

Contracts

CLMT

GEVO

Calumet, Gevo Shares Are Soaring Wednesday: What's Going On?

In a marked reversal, PepsiCo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) says it will be adding more chips to some bags in a move designed to lure consumers who have grown <a href="https://www.benzinga.com/personal-finance/24/09/41027068/kevin-oleary-says-we-need-answers-not-kumbaya-politics-takes-aim-at-harris-for-offering-no-real-">tired of "shrinkflation." </a>
The Details: According to a CNN <a href="https://www.cnn.com/2024/10/16/business/tostitos-chips-shrinkflation-pepsi/index.html">report</a>, the largest snack manufacturer in the U.S. will fight back against the trend of smaller sizes at higher prices.&nbsp;
PepsiCo, which produces Lay's, Tostitos, Doritos and Ruffles brand snacks, will begin offering Tostitos and Ruffles "bonus" bags that contain 20% more chips for the same price as the standard size. The company will also be adding two additional chip bags to its 18-bag variety-pack option, the spokesperson told CNN. 
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41340022/amazon-analyst-expects-q3-earnings-with-revenue-growth-margin-expansion-relative-st">Amazon Analyst Expects Q3 Earnings With Revenue Growth, Margin Expansion, Relative Stable E-Commerce Demand</a>
TD Cowen analyst Robert Moskow said Pepsi's competitors will likely follow suit and increase the size of their packaging. The TD Cowen analyst highlighted increasing snack prices which have grown 36% since 2020, outpacing a 21% increase in overall grocery prices. 
The average price of 16-ounce potato chips in September 2024 was $6.46, up from $5.02 in September 2020, <a href="https://fred.stlouisfed.org/series/APU0000718311">according to the Bureau of Labor Statistics.</a>
Pepsi&#8217;s Profits Shrink: Cash-strapped consumers have reacted to the higher prices by purchasing fewer snacks.&nbsp; PepsiCo's snack sales fell 1% <a href="https://www.benzinga.com/news/earnings/24/10/41225048/pepsico-adjusts-2024-revenue-expectations-after-mixed-q3-performance-and-global-challenges">last quarter</a>, snack volumes dropped 1.5% and the company's third-quarter revenue was more than $500 million below the Street's estimate, according to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>.&nbsp;
Pepsi CEO Ramon Laguarta addressed the issue in the company's earnings call last week.&nbsp;
&#8220;The cumulative impacts of inflationary pressures and higher borrowing costs over the last few years have continued to impact consumer budgets and spending patterns,&#8221; Laguarta said.
PepsiCo is hoping to revive its snack food segment by providing more value to its customers in the form of more chips per bag.&nbsp;
PEP Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, PepsiCo shares ended Wednesday's session down 0.81% at $174.48. 
Read Also: 
<ul>
<li><a href="https://www.benzinga.com/government/24/10/41346351/cybersecurity-firm-warns-of-threats-to-2024-presidential-election-integrity">Cybersecurity Firm Warns Of Threats</a></li>
</ul>

Pepsi Fights Back Against Shrinkflation: Why Your Chip Bags Will Be Fuller In The Future

Synovus Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>) reported quarterly earnings of $1.23 per share which beat the analyst consensus estimate of $1.08 by 13.89 percent. This is a 46.43 percent increase over earnings of $0.84 per share from the same period last year. The company reported quarterly sales of $564.720 million which beat the analyst consensus estimate of $559.198 million by 0.99 percent. This is a 2.62 percent increase over sales of $550.298 million the same period last year.

Synovus Finl Q3 2024 Adj. EPS $1.23 Beats $1.08 Estimate, Sales $564.720M Beat $559.198M Estimate

Oriental Rise Holding Limited is an integrated supplier of tea products in mainland China.&nbsp;
The ordinary shares are expected to commence trading on Nasdaq Capital Market under the ticker symbol &quot;ORIS&quot; on October 17, 2024.
&nbsp;

IPOs

ORIS

Oriental Rise Holding Prices IPO Of 1.75M Ordinary Shares At $4 Per Share, For Total Gross Proceeds Of $7M

With less than three weeks left before <a href="https://www.benzinga.com/topic/election-day">Election Day</a>, Smart &amp; Safe Florida, the campaign behind Florida&#8217;s marijuana legalization ballot, <a href="https://www.benzinga.com/markets/cannabis/24/04/38034138/florida-supreme-court-approves-cannabis-legalization-proposal-for-november-election-in-blow-to-d" target="_blank" rel="noreferrer noopener">Amendment 3</a>, has released a pair of new ads, including one that features clips of former President <a href="https://www.benzinga.com/topic/donald-trump">Donald Trump </a>endorsing the cannabis reform proposal, which he <a href="https://www.benzinga.com/markets/cannabis/24/08/40666944/donald-trump-supports-cannabis-legalization-in-florida-game-changer-and-huge-blow-to-ron-desanti">did at the end of August</a>.
Smart &amp; Safe, which has been ramping up its advertising over the past several weeks, has increasingly and wisely leaned into messaging about the bipartisan appeal of the legalization measure. That strategy was employed in the campaign&#8217;s use of the Trump endorsement, which by the way was not warmly greeted by Gov. <a href="https://www.benzinga.com/topic/ron-desantis">Ron DeSantis</a>, who continues to deplore the idea of legal cannabis in Florida where Trump is a resident.
Read Also:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/10/41365515/ron-desantis-pregnant-pigs-and-floridas-cannabis-legalization-battle-over-constitutional-amendme" target="_blank" rel="noreferrer noopener">Ron DeSantis, Pregnant Pigs And Florida's Cannabis Legalization: Battle Over Constitutional Amendment Rages</a>
The new ad featuring Trump, title "<a href="https://smartsafeflorida.cmail20.com/t/y-l-mkhdye-hrudilkrkr-k/" target="_blank" rel="noreferrer noopener">Good</a>," shows the former president talking about his support for the amendment&nbsp;during a podcast interview last month, wherein he says cannabis reform is "going to be very good" for Florida. "It's got to be done in a very concerted, lawful way. And the way they're doing it in Florida, I think is going to be actually good," Trump said. 
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Good &#x7C; Vote Yes on Amendment 3!" width="500" height="281" src="https://www.youtube.com/embed/rGinjQMP4D0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
The Smart &amp; Safe ad concludes with a message: "Amendment 3 legalizes marijuana for adults. Safe, lab-tested and regulated — generating billions for schools and law enforcement. Join President Donald Trump. Vote ‘yes' on Amendment 3."
In the "<a href="https://smartsafeflorida.cmail20.com/t/y-l-mkhdye-hrudilkrkr-h/" target="_blank" rel="noreferrer noopener">Right Way</a>" ad, Republican State Sen. Joe Gruters outlines that while Florida "is the freest state in America, we still have outdated marijuana laws obstructing that freedom. Amendment 3 would give adults back that freedom, and give Florida a chance to legalize marijuana responsibly."
Read Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41368890/florida-sheriff-backs-cannabis-legalization-amendment-im-a-conservative-with-strong-faith-and-fa">Florida Sheriff Backs Cannabis Legalization Amendment: &#8216;I&#8217;m A Conservative With Strong Faith And Family Values&#8217;</a></li>
</ul>
Photo: Shutterstock; Eugenio Cuppone via Pixabay

Legal

Donald Trump Appears In Florida Cannabis Legalization Campaign Ad, Discussing His Support For Legal Marijuana

WIIM

LBRT

Liberty Energy shares are trading lower after the company reported Q3 earnings and sales below estimates.

The redemption date will be&nbsp;December 16, 2024.&nbsp; The redemption price with respect to any redeemed note will equal&nbsp;100%&nbsp;of the principal amount thereof, plus accrued and unpaid interest, from&nbsp;July 15, 2024, to, but excluding the redemption date.&nbsp;&nbsp;

MongoDB Issues Notice Of Redemption For All $1.149B Of Its 0.25% Convertible Senior Notes Due 2026

Quoin Pharmaceuticals Non-GAAP EPS of -$1.11 misses by $0.70

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Quoin Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/qnrx-stock-quote/">QNRX</a>) just reported results for the first quarter of 2024.<ul><li>Quoin Pharmaceuticals reported earnings per share of -$1.11. This was below the analyst estimate for EPS of -76 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/qnrx-stock-earnings-quoin-pharmaceuticals-for-q1-of-2024/">QNRX Stock Earnings: Quoin Pharmaceuticals Misses EPS for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

QNRX Stock Earnings: Quoin Pharmaceuticals Misses EPS for Q1 2024

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zevra Therapeutics (ZVRA – Research Report), ALX Onc...

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), ALX Oncology Holdings (ALXO) and Quoin Pharmaceuticals (QNRX)

Quoin Pharmaceuticals Ltd (QNRX) has disclosed a new risk, in the Share Price & Shareholder Rights category. Quoin Pharmaceuticals Ltd. is grapplin...

Quoin Pharmaceuticals on the Brink: Nasdaq Deficiency Notice Threatens Stability and Investor Confidence

Maxim Group analyst Naz Rahman maintained a Buy rating on Quoin Pharmaceuticals (QNRX – Research Report) yesterday and set a price target of $4.00....

Buy Rating Affirmed for Quoin Pharmaceuticals Amidst Progress in Rare Dermatological Treatments

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning!



Moving stocks this morning are earnings reports, a settlement agreement, the pricing of a public offering and more.



Let&rsquo;s get into that below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Warrantee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock is rocketing close to 254% alongside heavy pre-market trading.</li>



<li>Nature&rsquo;s Miracle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) shares are soaring more than 122% with strong early morning trading.</li>



<li>Volato (NYSEMKT:<a href="https://investorplace.com/stock-quotes/soar-stock-quote/">SOAR</a>) stock is surging nearly 78% with heavy early morning trading today.</li>



<li>Frequency Electronics (NASDAQ:<a href="https://investorplace.com/stock-quotes/feim-stock-quote/">FEIM</a>) shares are rising almost 33% alongside its <a href="https://www.marketwatch.com/story/frequency-electronics-shares-climb-on-higher-4q-earnings-a32189da">Q4 earnings report</a>.</li>



<li>Mammoth Energy Services (NASDAQ:<a href="https://investorplace.com/stock-quotes/tusk-stock-quote/">TUSK</a>) stock is heading over 29% higher after <a href="https://www.nasdaq.com/press-release/cobra-acquisitions-llc-announces-settlement-agreement-prepa-2024-07-22">announcing a settlement agreement</a>.</li>



<li>ENGlobal (NASDAQ:<a href="https://investorplace.com/stock-quotes/eng-stock-quote/">ENG</a>) shares are gaining more than 22% without any clear news.</li>



<li>Wheeler Real Estate IT (NASDAQ:<a href="https://investorplace.com/stock-quotes/whlr-stock-quote/">WHLR</a>) stock is jumping over 20% with no news to report.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) shares are climbing more than 19% despite a lack of news on Tuesday.</li>



<li>SCYNEXIS (NASDAQ:<a href="https://investorplace.com/stock-quotes/scyx-stock-quote/">SCYX</a>) stock is getting an over 15% boost on a <a href="https://www.nasdaq.com/press-release/scynexis-receive-10-million-milestone-payment-gsk-triggered-delivery-completed-furi">$10 million milestone payment</a>.</li>



<li>Professional Diversity (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipdn-stock-quote/">IPDN</a>) shares are up more than 13% on Tuesday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>TransCode Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/">RNAZ</a>) stock is crashing more than 59% after <a href="https://www.nasdaq.com/press-release/transcode-therapeutics-inc-announces-pricing-public-offering-2024-07-22">pricing a public offering</a>.</li>



<li>Mira Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) shares are plummeting close to 31% <a href="https://investorplace.com/2024/07/why-is-mira-pharmaceuticals-mira-stock-up-318-today/">after a massive rally yesterday</a>.</li>



<li>Brera (NASDAQ:<a href="https://investorplace.com/stock-quotes/brea-stock-quote/">BREA</a>) stock is diving nearly 25% with strong pre-market trading this morning.</li>



<li>CareMax (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmax-stock-quote/">CMAX</a>) shares are tumbling over 22% <a href="https://www.benzinga.com/news/24/07/39892411/caremax-shares-are-up-by-more-than-200-what-you-need-to-know">after a rally yesterday</a>.</li>



<li>Nukkleus (NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/">NUKK</a>) stock is taking a more than 19% beating after a recent rally.</li>



<li>Castellum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ctm-stock-quote/">CTM</a>) shares are sliding over 19% <a href="https://investorplace.com/2024/07/why-is-castellum-ctm-stock-moving-today/">alongside volatility yesterday</a>.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is falling almost 16% as shares <a href="https://investorplace.com/2024/07/why-is-exicure-xcur-stock-down-27-today/">continue to come off a recent rally</a>.</li>



<li>Quoin Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/qnrx-stock-quote/">QNRX</a>) shares are dropping more than 15% today.</li>



<li>Polaris (NYSE:<a href="https://investorplace.com/stock-quotes/pii-stock-quote/">PII</a>) stock is slipping over 15% after <a href="https://www.marketwatch.com/story/polaris-stock-tumbles-11-after-earnings-fall-far-short-of-consensus-and-company-cuts-full-year-outlook-c3299335">missing earnings estimates</a>.</li>



<li>Netcapital (NASDAQ:<a href="https://investorplace.com/stock-quotes/ncpl-stock-quote/">NCPL</a>) shares close out our pre-market stock movers down more than 14%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-23rd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Quoin Pharmaceuticals reports Q2 results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Quoin Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/qnrx-stock-quote/">QNRX</a>) just reported results for the second quarter of 2024.<ul><li>Quoin Pharmaceuticals reported earnings per share of -39 cents. This was above the analyst estimate for EPS of -61 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/qnrx-stock-earnings-quoin-pharmaceuticals-for-q2-of-2024/">QNRX Stock Earnings: Quoin Pharmaceuticals Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

QNRX Stock Earnings: Quoin Pharmaceuticals Beats EPS for Q2 2024

Maxim Group analyst Naz Rahman reiterated a Buy rating on Quoin Pharmaceuticals (QNRX – Research Report) yesterday. The company's shares opened tod...

Comments

Quoin Pharmaceuticals

Noticias

Últimas noticias sobre Quoin Pharmaceuticals (NASDAQ:QNRX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL